For: | Khan S, Suryavanshi M, Kaur J, Nayak D, Khurana A, Manchanda RK, Tandon C, Tandon S. Stem cell therapy: A paradigm shift in breast cancer treatment. World J Stem Cells 2021; 13(7): 841-860 [PMID: 34367480 DOI: 10.4252/wjsc.v13.i7.841] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v13/i7/841.htm |
Number | Citing Articles |
1 |
Marina Ibragimova, Matvey Tsyganov, Nikolai Litviakov. Tumour Stem Cells in Breast Cancer. International Journal of Molecular Sciences 2022; 23(9): 5058 doi: 10.3390/ijms23095058
|
2 |
Muhammad Safdar, Mehmet Ozaslan, Yasmeen Junejo, Iffat Saeed Channa. Cytotoxic and anticancer activity of a novel synthesized tet-AuNPs simultaneously activates p53 and inhibits NF-kB signaling in SKBR3 cell line. Toxicology and Environmental Health Sciences 2022; 14(1): 69 doi: 10.1007/s13530-021-00118-1
|
3 |
Weijie Zhang, Lei Shi, Wei Zhou, Xin Liu, Yuan Xi, Xinyin Wang, Ya Li, Xia Xu, Youcai Tang. Oridonin impedes breast cancer growth by blocking cells in S phase and inhibiting the PI3K/AKT/mTOR signaling pathway. Heliyon 2023; 9(7): e18046 doi: 10.1016/j.heliyon.2023.e18046
|
4 |
Ryan Lim, Avinanda Banerjee, Ritusree Biswas, Anana Nandakumar Chari, Srikala Raghavan. Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.966662
|
5 |
Lisbeth Escudero Mendez, Mirra Srinivasan, Ranim K Hamouda, Baba Ambedkar, Hadia Arzoun, Isra Sahib, Jack Fondeur, Lubna Mohammed. Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer. Cureus 2022; doi: 10.7759/cureus.28056
|
6 |
Zhebin Xiang, Bo Ma, Xiujun Pei, Wenjie Wang, Weilun Gong. Mechanism of action of genistein on breast cancer and differential effects of different age stages. Pharmaceutical Biology 2025; 63(1): 141 doi: 10.1080/13880209.2025.2469607
|
7 |
Sabina Sblano, Angelina Boccarelli, Caterina Deruvo, Gabriella La Spada, Modesto de Candia, Rosa Purgatorio, Cosimo Damiano Altomare, Marco Catto. The potential of MAO inhibitors as chemotherapeutics in cancer: A literature survey. European Journal of Medicinal Chemistry 2025; 283: 117159 doi: 10.1016/j.ejmech.2024.117159
|
8 |
Esma Karahmet Farhat, Emina Karahmet Sher, Amina Džidić-Krivić, Ines Banjari, Farooq Sher. Functional biotransformation of phytoestrogens by gut microbiota with impact on cancer treatment. The Journal of Nutritional Biochemistry 2023; 118: 109368 doi: 10.1016/j.jnutbio.2023.109368
|
9 |
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, Rekha Rani Kokkanti, Qi-En Wang. ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy. Life Sciences 2024; 356: 123033 doi: 10.1016/j.lfs.2024.123033
|
10 |
Yihan Wang, Kuldip Singh, Chunxin Lu, Kogularamanan Suntharalingam. Anti-Cancer Stem Cell Properties of Square Planar Copper(II) Complexes with Vanillin Schiff Base Ligands. Molecules 2025; 30(7): 1636 doi: 10.3390/molecules30071636
|
11 |
Mai Nguyen, Clodia Osipo. Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens. International Journal of Molecular Sciences 2022; 23(12): 6813 doi: 10.3390/ijms23126813
|
12 |
Narjes Azadbakht, Abbas Doosti, Mohammad-Saeid Jami. CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes. Biological Procedures Online 2022; 24(1) doi: 10.1186/s12575-022-00171-1
|
13 |
Jing Peng, Wenhui Liu, Jiaju Tian, Yuncong Shu, Rui Zhao, Yuping Wang. Non-coding RNAs as key regulators of epithelial-mesenchymal transition in breast cancer. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1544310
|